Magnesium and melatonin supplement for sleep in people with nighttime leg cramps
Tests a magnesium and melatonin supplement for sleep in adults with nighttime leg cramps.
Key facts
- Who runs it
- StudySetGo
- Where
- Atlanta, Birmingham, Charleston, Charlotte, Little Rock, Nashville, and Palm Beach Gardens, United StatesSee the 7 sites
- Trial code
- Registry title
- The Effect of a Daily Magnesium and Melatonin Supplement on Sleep Quality in People With Nighttime Leg Cramps
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 10 Oct 2026
- Expected to end
- 10 Sept 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Magnesium and melatonin based multi-ingredient dietary supplementation
- Placebo
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in Florida who sleep poorly because of nighttime leg cramps. It tests a magnesium and melatonin supplement against a placebo (a dummy pill).
- Age
- 40 to 75 years
- Sex
- All sexes can join
- Disease stage
- Poor sleep quality you report yourself (PSQI >5), and nighttime leg cramps averaging ≥4 episodes per fortnight.
- Earlier treatment
- You cannot join if you use melatonin, magnesium, or other supplements for sleep or leg cramps now or within 4 weeks before the start. You cannot join if you take any prescription medicine now.
Main reasons for not taking part
- A diagnosed sleep disorder, such as sleep apnoea, restless legs syndrome or insomnia disorder
- A known other cause of the leg cramps, such as blood vessel, nerve, kidney or thyroid problems
- Current or past heart and blood vessel disease, diabetes, autoimmune, gut, nerve, liver or kidney disease, or severe mental illness
- Cancer, unless in confirmed remission with all treatment finished
- Pregnant, breastfeeding or planning pregnancy; shift work or irregular sleep; not living permanently in Florida
The registry criteria, word for word
Show all 26 criteriaShow less
Who can take part
- Adults aged 40-75 years
- Self-reported poor sleep quality (PSQI >5) at screening
- Self-reported nocturnal leg cramp averaging ≥4 episodes per fortnight at screening
- Capacity to understand and provide electronic informed consent
- Willing to wear an Oura Ring wearable device continuously throughout the study period
- Access to a smartphone/tablet with iOS 15 or higher and Android 9 or higher and willing to install and use the Oura and Trialflare applications
- Be a resident of and permanently living in Florida with no planned travel across more than one time zone for at least 1 night during the study period
Who cannot take part
- Current use of any prescription medication
- Any current or prior diagnosis of:
- Diagnosed sleep disorder (e.g. obstructive sleep apnoea, restless legs syndrome, insomnia disorder)
- Known or suspected secondary cause of nocturnal leg cramps (e.g. peripheral vascular disease, neurological condition, renal impairment, thyroid disorder)
- Cancer or malignancy of any kind (prior malignancy is not exclusionary if the participant is in confirmed remission and has completed all treatment)
- Cardiovascular disease (e.g. hypertension, coronary artery disease, heart failure, arrhythmia, stroke, peripheral vascular disease)
- Autoimmune disorder (e.g. rheumatoid arthritis, lupus, multiple sclerosis)
- Gastrointestinal disorder (e.g. IBS, malabsorption syndromes)
- Neurological disorder (e.g. epilepsy, Parkinson's disease, dementia)
- Hepatic or renal impairment
- Diabetes mellitus (type 1 or type 2)
- Severe psychiatric disorder (e.g. schizophrenia, bipolar disorder)
- Known hypersensitivity or allergy to any ingredient in the active or placebo product
- Current or recent (within 4 weeks of randomisation) use of melatonin, magnesium, or other supplements specifically taken for sleep or leg cramps or listed as an ingredient of the intervention supplement
- Myasthenia Gravis
- Rotating shift work or irregular sleep patterns
- Current participation in another interventional clinical trial
- Inability to comply with study procedures or remote visit schedule
- Breastfeeding, pregnant, or planning to become pregnant during the study period
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 75 years old?
Where in United States
- Remote participation (home-based, no site visits)Atlanta, United StatesContact: Christopher Koscien, PhDTaking people
- Remote participation (home-based, no site visits)Birmingham, United StatesContact: Christopher Koscien, PhDTaking people
- Remote participation (home-based, no site visits)Charleston, United StatesContact: Christopher Koscien, PhDTaking people
- Remote participation (home-based, no site visits)Charlotte, United StatesContact: Christopher Koscien, PhDTaking people
- Remote participation (home-based, no site visits)Little Rock, United StatesContact: Christopher Koscien, PhDTaking people
- Remote participation (home-based, no site visits)Nashville, United StatesContact: Christopher Koscien, PhDTaking people
- Remote participation (home-based, no site visits)Palm Beach Gardens, United StatesContact: Tom JamesonTaking people
About the trial
What the trial wants to find out
Participants are being invited to take part in a research study. Before deciding whether to take part, it is important for participants to understand why the research is being done and what it will involve.
Read full original descriptionShow less
Purpose: This study will investigate whether a multi-ingredient nutritional supplement containing magnesium and melatonin can improve sleep quality in adults who experience disrupted sleep due to nighttime leg cramps.
What participation involves: Participation lasts 8 weeks. Participants will be randomly assigned to take either the nutritional supplement or a placebo (inactive look-alike) every night before bed for 6 weeks. Participants will wear an Oura Ring wearable device on one finger continuously for 8 weeks throughout the study and complete short questionnaires using a smartphone app. The Oura Ring and study supplement will be sent to the participant's home address. Participants will never need to travel to a research centre; all contact with the research team will be by video call, phone, messaging, or email.
How long: Total involvement will be 8 weeks, made up of a 2-week baseline period and a 6-week supplementation period. Each day, participants will complete a short app-based questionnaire (approximately 1 minute). At the end of weeks 2, 4, 6, and 8, participants will complete additional app-based questionnaires (approximately 10 minutes).
The 2 groups in the trial
- Magnesium and melatonin based multi-ingredient dietary supplementTreatment being tested
Treatment: Magnesium and melatonin based multi-ingredient dietary supplementation
- PlaceboPlacebo, for comparison
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- An Investigation Into the Effect of a Daily Magnesium and Melatonin Based Multi-Ingredient Dietary Supplement on Sleep Quality in Individuals With Self-Reported Nighttime Leg Cramps.
- Plain-language title
- Magnesium and melatonin supplement for sleep in people with nighttime leg crampsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07651514, who can take part
- Record updated
- 2 November 2026